Table 2 Description of novel mutations
GeneSubstitutionNumber of affected peopleParental analysisNumber of negative controls testedPathogenic mutation affecting the same residueInterspecies conservation†PolyPhen predictionConclusion
This studyLiterature*
BRAFT241P1De novo200155YesProbably damagingMutation
Q262R1Absent in mother200155S in DrosophilaBenignMutation (probable)
G464R1200YesProbably damagingMutation (probable)
E501V1200105E501G, E501KYesProbably damagingMutation (probable)
N581K1De novoYesProbably damagingMutation
MEK1E44G1Mutated in asymptomatic mother200T in DrosophilaPossibly damagingPossible rare polymorphism
T55P1200S in DrosophilaPossibly damagingMutation (probable)
D67N3De novo (2 patients)200YesBenignMutation
MEK2L46_E55del1De novo20050Mutation
K61T1De novo20050K61EYesBenignMutation
A62P2De novo (2 patients)20050E in C elegansBenignMutation
KRASK5E1200>500YesProbably damagingMutation
G12S1Absent in mother200>500Somatic G12SYesBenignMutation
  • *BRAF, MEK1 and MEK2 negative controls were tested in Niihori et al13 Norumi et al.20

  • †When orthologous genes were present, the human sequence was compared with that of Mus musculus, Rattus norvegicus, Danio rerio, Drosophila melanogaster and Caenorhabditiselegans.